Synthesis and Properties of ordered Mesoporous SiO2-CaO Bioactive glasses by DAVID LUKITO
 SYNTHESIS AND PROPERTIES OF ORDERED 
























A THESIS SUBMITTED  
FOR THE DEGREE OF MASTER OF SCIENCE 
DEPARTMENT OF MATERIALS SCIENCE 





I would like to express my deepest gratitude to my supervisor Dr. Xue Jun Min for his 
advice and guidance throughout the entire course of my project and Associate Professor 
John Wang for giving me the opportunity to do this project under his supervision. I am 
deeply impressed by the passion and dedication of both of them on research. I would 
forever treasure all the invaluable lessons I learnt from them. 
 
I want to thank all the member of advance ceramic group for the assistance and 
discussions throughout the whole course. Special appreciations are due to Dr. Zhou 
Zhaohui for his invaluable advice, constant support and most importantly, for being a 
great friend. I also want to thank all the staff and lab technician in the department of 
Materials Science and Engineering as well as those from other departments, especially 
Liu Binghai and Ms Frances from Chemistry department. 
 
I also would like to acknowledge the financial support from National University of 
Singapore for my project. 
 
Last but not least, I am very grateful for all the love, constant support and encouragement 





Table of Contents 
Acknowledgements i 
Table of Contents ii 
Summary vi 
List of Tables viii 
List of Figures ix 
 
Chapter One – Introduction 1 
1.1 Bioactive Glasses 2 
1.1.1 What Are Bioactive Glasses? 2 
1.1.2 Bioactivities of Bioactive Glasses 3 
1.1.3 Application of Bioactive Glasses 4 
1.2 Preparation Methods of Bioactive Glasses 5 
1.2.1 Melting Process 5 
1.2.2 Sol – Gel Process  7 
1.3 Effects of Glass Texture on Bioactivities  9 
1.4 Factors Affecting Textures of Bioactive Glasses 11 
1.5 Ordered Mesoporous Structure  13 
1.6 Bioactive Glasses as Drug Delivery Materials  17 
1.7 Bioactive Glasses – Polymer Composites as Drug Delivery Materials  19 




Chapter Two – Project Objectives and Scopes of Research 28 
2.1 Project Objectives 29 
2.2 Thesis Layouts 30 
 
Chapter Three – Characterization Techniques 31 
3.1 Thermogravimetric Analysis (TGA) 32  
3.2 X – Ray Diffraction (XRD) 32 
3.3 Infrared Spectroscopy (IR) 33 
3.4 Scanning Electron Microscopy (SEM) 35 
3.5 Transmission Electron Microscopy (TEM) 36 
3.6 Specific surface area and porosity analysis 38 
3.7 Ultraviolet Visible spectroscopy (UV – VIS) 40 
3.8 Inductively Coupled Plasma (ICP) 41 
3.9 Gel Permeation Chromatography (GPC) 42 
3.10 References 44 
 
Chapter Four – Formation and Bioactivities of Ordered Mesoporous Bioactive 
Glasses 45 
4.1 Experimental Procedures 46 
4.1.1 Preparation of Ordered Mesoporous Bioactive Glasses 46 
4.1.2 Bioactivity Test 47 
4.1.3 Characterization 48 
4.2 Results and Discussion 49  
 iv 
4.2.1 Formation of Ordered Mesoporous Bioactive Glasses 49 
4.2.1.1 Effects of CaO on Formation of Ordered Mesoporous 
Structure 49 
4.2.1.2 Effects of CaO on Pore Size of Ordered Mesoporous 
Bioactive Glasses 55 
4.2.1.3 Effects of TMB on Pore Size of Ordered Mesoporous 
Bioactive Glasses  59 
4.2.2 Bioactivities of Ordered Mesoporous Bioactive Glasses 63 
4.3 Remarks 74 
4.4 References 75 
  
Chapter Five – Drug Loaded Bioactive Glasses and Composite Microspheres 76 
5.1 Experimental Procedures 77 
5.1.1 Preparation of Gentamicin Loaded Bioactive Glasses 78 
5.1.2 Preparation of Bioactive Glasses – PLGA Composite Microspheres 78  
5.1.3 Characterization 79 
5.2 Results and Discussion 80 
5.2.1 Gentamicin Loaded Bioactive Glasses  80 
5.2.1.1 Drug Release Properties of Gentamicin Loaded Bioactive 
Glasses  80 
5.2.1.2 Bioactivities of Gentamicin Loaded Bioactive Glasses  84 
5.2.2 Bioactive glasses – PLGA Composite Microspheres 96 
 v 
5.2.2.1 Drug Release Properties of Bioactive Glasses – PLGA 
Composite Microspheres 98 
5.2.2.2 Bioactivities of Bioactive Glasses – PLGA Composite 
Microspheres 103 
5.3 Remarks 110 
5.4 References 111 
 
Chapter Six – Conclusions and Future Works 112 
6.1 Conclusions 113 




















Bioactive glasses are very interesting materials due to their unique bioactivity properties. 
In this project, formation and bioactivities of ordered mesoporous bioactive glasses in the 
SiO2 – CaO system were investigated systematically. The applications of these ordered 
mesoporous bioactive glasses as drug carriers were also studied. 
 
Formation of ordered mesoporous bioactive glasses via a surfactant templating route was 
studied in connection with the presence of CaO in SiO2 glass network. The complexation 
between Ca2+ and the hydrophilic group of P123 surfactant made it possible to form 
bioactive glasses with highly ordered mesoporous structure. The average pore size of the 
ordered mesoporous bioactive glasses was influenced by the amounts of CaO in the 
bioactive glasses system. It is also possible to vary the average pore size of the bioactive 
glasses by adding 1,3,5 Trimethylbenzene (TMB) cosolvent into the system. It was 
observed that the ordered mesoporous structure would significantly improve the 
bioactivities of bioactive glasses. When the bioactivities of ordered mesoporous bioactive 
glasses and sol gel derived bioactive glasses of the same composition were compared, it 
was found that the formation rate of crystalline hydroxyapatite, Ca10(PO4)6(OH)2, on the 
surface of the ordered mesoporous bioactive glasses was much faster, as compared to that 
of sol gel derived bioactive glasses.  
 
As drug carriers, antibiotic gentamicin was incorporated into the ordered mesoporous 
bioactive glasses. The drug molecules were physically hosted in the mesopores, causing 
 vii 
high initial burst of drug release in the drug release profile. These prompted to the 
employment of poly(lactide-co-gycolide) (PLGA) polymer to encapsulate the drug 
loaded bioactive glasses to form composite microspheres. The composite microspheres 
possess lower initial burst with longer duration of drug release. The effects of gentamicin 
incorporation into bioactive glasses on the bioactivities were studied. The presence of 
gentamicin in the pores of bioactive glasses affects the bioactivities. The ion exchange 
between bioactive glasses and simulated body fluid (SBF) solution was hindered by the 
presence of gentamicin in the pores of bioactive glasses. The release of acidic drug, 
gentamicin, also lowered the pH value of SBF solution, which further reduced the 
bioactivities of bioactive glasses. However, the drug loaded bioactive glasses still 
possessed bioactivity behaviors although the bioactivities of drug loaded bioactive 
glasses were reduced. In addition, the PLGA microsphere encapsulation on the drug 
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